JacobSethBallonMDMPH

PubMed

• Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study.
  Jacob S Ballon, René S Kahn, Christina Arevalo, Martin Dunbar, David McDonnell
  The Journal of Clinical Psychiatry. 2024-12-04
• Inspire self report scale (ISRS): A feasibility study of a Novel self report scale for people with schizophrenia spectrum disorders.
  Vanika Chawla, Nandini Bansal, David Spelber, Aakash Desai, Levi Frehlich
  Journal of Psychiatric Research. 2023-09-01
• 9 citations
  Reductions in synaptic marker SV2A in early-course Schizophrenia.
  Jong H Yoon, Zhener Zhang, Elizabeth Mormino, Guido Davidzon, Michael J Minzenberg
  Journal of Psychiatric Research. 2023-05-01

Journal Articles

• Investigational treatments for cognitive impairment in schizophrenia  
  Levi L, Ballon JS, Kantrowitz JT, Current Psychiatry, 9/1/2013
• Polypharmacy for schizophrenia  
  Ballon J, Stroup TS, Curr Opin Psychiatry, 3/1/2013
• Advances in the Management of Treatment Refractory Schizophrenia  
  Ballon JS and Lieberman JA, Focus: The journal of lifelong learning in psychiatry, 1/1/2010
• Signaling pathways in schizophrenia: emerging targets and therapeutic strategies  
  Karam CS, Ballon JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, Markx S, Lieberman JA, Javitch JA, Trends Pharmacol Sci, 1/1/2010
• Teaching Pearls from the Lost Art of Psychopharmacology  
  Glick ID, Balon RJ, Ballon JS, Rovine D, Journal of Psychiatric Practice, 1/1/2009
• Psychopharmacology  
  Ballon JS, Wirshing DA, Schultz SC, 1/1/2009
• Obstetrical complications in people at risk for developing schizophrenia  
  Ballon JS, Dean KA, Cadenhead KS, Schizophrenia Research, 1/1/2008
• Diabetes in the Mentally Ill  
  Ballon JS, Fernandez JW, 1/1/2008
• Social functioning in adolescents at risk for schizophrenia  
  Ballon JS, Marks II, Cadenhead KS, Psychiatry Research, 1/1/2007
• Encyclopedia of Stress  
  Ballon JS, Boyd JA and Wirshing DA, 1/1/2007
• Case report of anasarca secondary to venlafaxine  
  Ballon JS, Schulman M, Journal of Clinical Psychopharmacology, 1/1/2006
• Modafinil: A systematic review of its potential clinical uses and mechanisms of action  
  Ballon JS, Feifel D, Journal of Clinical Psychiatry, 1/1/2006
• The effects of novel antipsychotic medications on weight gain, glucose, and lipid profiles  
  Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, and Wirshing WC, Journal of Clinical Psychiatry, 1/1/2002
• Molecular Pathophysiology of Metabolic Effects of Antipsychotic Medications  
  Ballon JS, Pajvani UB, Freyberg ZF, Leibel RL, Lieberman JA, Trends Endocrinology and Metabolism
• Neurocognitive and Daily Functioning in Individuals with Schizophrenia: Associations with Aerobic Fitness and Body Mass Index  
  Vakhrusheva J, Bartels MN, Armstrong HF, Ballon JS, Khan S, Chang RW, Hansen MC, Ayanruoh L, Smith EE, Sloan RP, Kimhy DA, Psychiatry Research
• Join now to see all

Books/Book Chapters

• Essentials of Psychopharmacology. 
  Chapter: Olanzapine. 
  Ballon JS, Wirshing DA, Schulz SCEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Inc.Edition 3rd,2013
• Management of Treatment Resistant Major Psychiatric Disorders. 
  Chapter: Treatment Resistant Schizophrenia. 
  Ballon JS, Lieberman JAEditors: Nemeroff CB.Oxford University Press2012
• Tarascon Neurosurgery Pocketbook 
  Chapter: Psychiatry 
  Ballon JS, Byers JAEditors: Hayden MG.Jones and Bartlett2011
• Tarascon Neurosurgery Pocketbook. 
  Chapter: Psychiatry. 
  Ballon JS, Byers JAEditors: Hayden MG.Jones and Bartlett2011
• Integrated Neuroscience and Personalized Medicine 
  Chapter: Personalized Medicine for Schizophrenia 
  Page 93 - 116Ballon JS, Girgis RR, Lieberman JAOxford University PressEdition 1st,2010
• Integrated Neuroscience and Personalized Medicine. 
  Chapter: Personalized Medicine for Schizophrenia. 
  Page 93 - 116Ballon JS, Girgis RR, Lieberman JAOxford University PressEdition 1st,2010
• Psychopharmacology 
  Chapter: Olanzapine 
  Ballon JS, Wirshing DA, Schultz SCEditors: Schatzberg AF and Nemeroff CB.American Psychiatric Press, Inc.Edition 4th,2009
• Diabetes in the Mentally Ill 
  Chapter: Diabetes and Mental Health 
  Ballon JS, Fernandez JWEditors: Boyd JA, Wirshing DA.Lippincott, Williams, Wilkins2008
• Encyclopedia of Stress 
  Chapter: Stress and Anxiety: Treatment with 2nd Generation Antipsychotic Drugs 
  Page 587 - 590Ballon JS, Boyd JA and Wirshing DAEditors: George Fink.Oxford: Academic PressEdition 2nd,2007
• Management of Treatment Resistant Major Psychiatric Disorders 
  Chapter: Treatment Resistant Schizophrenia 
  Ballon JS, Lieberman JAEditors: Nemeroff CB.Oxford University Press
• Essentials of Psychopharmacology 
  Chapter: Olanzapine 
  Ballon JS, Wirshing DA, Schulz SCEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Inc.Edition 3rd,
• Join now to see all

Abstracts/Posters

• Metformin and impaired glucose tolerance in overweight persons with schizophrenia.
  Ballon JS, Hamer RM, Catellier DJ, Stewart D, Lavange L, Golden L, Lieberman JA, Stroup TS, Jarskog LF, International Congress of Schizophrenia Research, Colorado Springs, CO, 4/6/2011
• Metformin and impaired glucose tolerance in overweight persons with schizophrenia
  Ballon JS, Hamer RM, Catellier DJ, Stewart D, Lavange L, Golden L, Lieberman JA, Stroup TS, Jarskog LF, International Congress of Schizophrenia Research; Schizophrenia Bulletin, Colorado Springs, CO, 4/6/2011
• Health services outcomes in veterans with schizophrenia and traumatic brain injury
  Ballon JS, Brooks JO, King R, Hoblyn J, International Congress of Schizophrenia Research; Schizophrenia Bulletin, San Diego, CA, 4/1/2009
• Health services outcomes in veterans with schizophrenia and traumatic brain injury.
  Ballon JS, Brooks JO, King R, Hoblyn J, International Congress of Schizophrenia Research, San Diego, CA, 4/1/2009
• Predictors of atypical antipsychotic prescriptions in 2,964 veterans with bipolar disorder
  Hoblyn, JC, Kurita, K, Rovine, D, Ballon, JS, & Brooks, JO, Annual Convention of the American Psychiatric Association, San Diego, CA, 1/1/2007
• Predictors of atypical antipsychotic prescriptions in 2,964 veterans with bipolar disorder.
  Hoblyn JC, Kurita K, Rovine D, Ballon JS, & Brooks JO, Annual Convention of the American Psychiatric Association, San Diego, CA, 1/1/2007
• The community re-entry program for schizophrenia: correlates of treatment response
  Wirshing DA, Wirshing WC, Rossotto E, Gonzalez L, Watson J, Ballon J, McNally C, American Psychiatric Association; New Research Program and Abstracts, New Orleans, LA, 5/8/2001
• Antipsychotic medication: impact on coronary artery disease risk factors
  Wirshing DA, Wirshing WC, Boyd J, Meng L, Ballon JS, American Psychiatric Association; New Research Programs & Abstracts, New Orleans, LA, 5/8/2001
• Antipsychotic medication: impact on coronary artery disease risk factors.
  Wirshing DA, Wirshing WC, Boyd J, Meng L, Ballon JS, New Research Programs & Abstracts, American Psychiatric Association, New Orleans, LA, 5/8/2001
• The community re-entry program for schizophrenia: correlates of treatment response.
  Wirshing DA, Wirshing WC, Rossotto E, Gonzalez L, Watson J, Ballon J, McNally C, American Psychiatric Association, New Research Program and Abstracts, New Orleans, LA, 5/8/2001
• Antipsychotic medication: impact on coronary artery disease risk factors
  Wirshing DA, Boyd J, Meng L, Ballon JS, Wirshing, WC, Society of Biological Psychiatry Annual Meeting; Supplement to Biological Psychiatry, New Orleans, LA, 5/5/2001
• The community re-entry program for schizophrenia: neurocognitive and psychopathologic correlates of treatment response
  Wirshing DA, Wirshing WC, Gonzalez L, Rossotto E, Watson J, Pierre JM, Kern RS, Hwang S, Ballon J, Pien J, Society of Biological Psychiatry; Supplement to Biological Psychiatry, New Orleans, LA, 5/5/2001
• Antipsychotic medication: impact on coronary artery disease risk factors.
  Wirshing DA, Boyd J, Meng L, Ballon JS, Wirshing, WC, Society of Biological Psychiatry Annual Meeting, Supplement to Biological Psychiatry, New Orleans, LA, 5/5/2001
• The community re-entry program for schizophrenia: neurocognitive and psychopathologic correlates of treatment response.
  Wirshing DA, Boyd J, Meng L, Ballon JS, Wirshing, WC, Society of Biological Psychiatry, Supplement to Biological Psychiatry, New Orleans, LA, 5/5/2001
• Antipsychotic medication impact on coronary artery disease risk factors
  Wirshing DA, Boyd JA, Meng LR, Ballon JS, Champion K, Wirshing WC, International Congress on Schizophrenia Research; Schizophrenia Research: An International Multidisciplinary Journal, Whistler, BC, 5/1/2001
• Antipsychotic medication impact on coronary artery disease risk factors.
  Wirshing DA, Boyd JA, Meng LR, Ballon JS, Champion K, Wirshing WC, International Congress on Schizophrenia Research, Schizophrenia Research: An International Multidisciplinary Journal, Whistler, BC, 5/1/2001
• The Community re-entry program for schizophrenia: preliminary findings
  Wirshing DA, Rossoto E, Gonzalez L, Watson J, Pierre JM, Smurda J, Sokolov G, Ballon JS, Pien J, and Wirshing WC, 52nd Institute of Psychiatric Services; Syllabus and Proceedings Summary, Philadelphia, PA, 10/25/2000
• The Community re-entry program for schizophrenia: preliminary findings.
  Wirshing DA, Rossoto E, Gonzalez L, Watson J, Pierre JM, Smurda J, Sokolov G, Ballon JS, Pien J, and Wirshing WC, 52nd Institute of Psychiatric Services, 2000 Syllabus and Proceedings Summary, Philadelphia, PA, 10/25/2000
• Impact of intensive psychoeducational training program on inpatients with schizophrenia: Does quality of life affect outcome?
  Rossoto E, Wirshing DA, Gonzalez L, Watson J, Pierre JM, Smurda J, Sokolov G, Ballon JS, Pien J, and Wirshing WC, Association for Clinical Psychosocial Research, Napa, CA, 10/12/2000
• The community re-entry program for schizophrenia: Neurocognitive and psychopathologic correlates of treatment response.
  Wirshing DA, Gonzalez L, Rossoto E, Smurda J, Sokolov G, Ballon JS, Pien J, Wirshing WC, West Coast College of Biological Psychiatry, San Diego, CA, 4/17/2000
• The community re-entry program for schizophrenia: Neurocognitive and psychopathologic correlates of treatment response
  Wirshing DA, Gonzalez L, Rossoto E, Smurda J, Sokolov G, Ballon JS, Pien J, Wirshing WC, West Coast College of Biological Psychiatry, Poster Session, San Diego, CA, 4/17/2000
• New psychotropic drugs for axis I disorders: Recently arrived, in development and never arrived.
  Glick ID, Belanoff JK, Ballon JS, 37th annual meeting of the American College of Neuropsychopharmacology, Las Croabas, PR, 12/15/1998
• New psychotropic drugs for axis I disorders: Recently arrived, in development and never arrived
  Glick ID, Belanoff JK, Ballon JS, 37th annual meeting of the American College of Neuropsychopharmacology, Poster Session 156, Las Croabas, Puerto Rico, 12/15/1998
• Join now to see all

Lectures

• Schizophrenia as a Systemic Disease: Implications on pathology and clinical management. 
  4/23/2014
• Targeting Cognition in Schizophrenia: Current Research studies at Columbia 
  10/9/2013
• Targeting Cognition in Schizophrenia: Current Research studies at Columbia. 
  10/9/2013
• Schizophrenia as Systemic Disease 
  10/7/2013
• Mechanism of Action of Stimulants 
  Chicago, IL - 10/1/2011
• Mechanism of Action of Stimulants. 
  Chicago, IL - 10/1/2011
• Metformin and impaired glucose tolerance in overweight persons with schizophrenia 
  Colorado Springs, CO - 4/6/2011
• Metformin and impaired glucose tolerance in overweight persons with schizophrenia. 
  Colorado Springs, CO - 4/6/2011
• Join now to see all